Skip to main content
Donate
Login
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Search
Donate
Login
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2024
Research & Education
Research & Education
Scientific Projects
Scientific Projects
IASLC Staging Project: Lung Cancer, Thymic Tumors, and Mesothelioma
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Past IASLC Scientific Projects
Lung Cancer 360
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Early-Career Opportunities
Early-Career Opportunities
IASLC Academy
Publications, Resources & Guidelines
News
News
ILCN
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
IASLC Partnerships
Patient Advocacy
Patient Advocacy
STARS
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 1873 - 1884 items out of 1999 results
ILCN article
Scientist, Advocate, and Leader: A Q&A with Dr. Jennifer King
ILCN article
Global Survey Aims to Provide Insights on Biomarker Testing
ILCN article
Multidisciplinary Team to Chair 2025 World Conference
ILCN article
US Approves Osimertinib with Chemotherapy for EGFR+ NSCLC; Approvals Pending in Other Countries
ILCN article
Food as Medicine: Research Aims to Understand the Power of Nutrition in Treating Cancer
ILCN article
Debaters Argue Merits of Surgery in Malignant Meso in Light of MARS2 Data
ILCN article
Can pCR Be an Early Clinical Trial Endpoint? Initiative Aims to Answer That Question
ILCN article
Words Matter: Coping with Misinformation in Healthcare
ILCN article
US FDA Approves Frontline Amivantamab Combination for Patients with EGFR exon 20 Insertion-mutated NSCLC
ILCN article
Regulating Artificial Intelligence
ILCN article
Experts Debate Addition of Frontline Chemotherapy for EGFR+ NSCLC
ILCN article
Should Biomarkers Be Used in the Clinical Management of ES-SCLC?
Pagination
First
First page
‹
Previous page
…
153
154
155
156
157
158
159
160
161
…
›
Next page
Last
Last page